Medios AG (0QB4.L)
EUR 11.61
(-0.29%)
EUR 11.61
(-0.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 125.94 Million EUR | -1.54% |
| 2022 | 127.91 Million EUR | -1.59% |
| 2021 | 129.97 Million EUR | 149.42% |
| 2020 | 52.11 Million EUR | 49.14% |
| 2019 | 34.94 Million EUR | 25.15% |
| 2018 | 27.91 Million EUR | 74.17% |
| 2017 | 16.03 Million EUR | 16.48% |
| 2016 | 13.76 Million EUR | 7321.68% |
| 2015 | 185.43 Thousand EUR | 106.53% |
| 2014 | 89.78 Thousand EUR | -60.37% |
| 2013 | 226.54 Thousand EUR | -15.52% |
| 2012 | 268.14 Thousand EUR | -4.48% |
| 2011 | 280.72 Thousand EUR | -45.84% |
| 2010 | 518.32 Thousand EUR | 117.75% |
| 2009 | -2.92 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 429.37 Million EUR | 172.2% |
| 2024 Q1 | 157.74 Million EUR | 25.24% |
| 2023 Q2 | 170.15 Million EUR | 2.61% |
| 2023 Q3 | 159.9 Million EUR | -6.02% |
| 2023 FY | 125.94 Million EUR | -1.54% |
| 2023 Q4 | 125.94 Million EUR | -21.24% |
| 2023 Q1 | 165.82 Million EUR | 29.64% |
| 2022 Q4 | 127.91 Million EUR | -10.73% |
| 2022 Q2 | 181.1 Million EUR | 3.87% |
| 2022 FY | 127.91 Million EUR | -1.59% |
| 2022 Q1 | 174.35 Million EUR | 34.14% |
| 2022 Q3 | 143.28 Million EUR | -20.88% |
| 2021 Q1 | 141.13 Million EUR | 170.83% |
| 2021 Q3 | 137.61 Million EUR | 4.09% |
| 2021 Q4 | 129.97 Million EUR | -5.55% |
| 2021 FY | 129.97 Million EUR | 149.42% |
| 2021 Q2 | 132.21 Million EUR | -6.32% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 52.11 Million EUR | 49.14% |
| 2020 Q4 | 52.11 Million EUR | -24.45% |
| 2020 Q3 | 68.97 Million EUR | 8.7% |
| 2020 Q2 | 63.45 Million EUR | 0.0% |
| 2019 Q4 | 34.94 Million EUR | 0.0% |
| 2019 FY | 34.94 Million EUR | 25.15% |
| 2019 Q2 | 36.62 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q1 | 20.59 Million EUR | 28.48% |
| 2018 FY | 27.91 Million EUR | 74.17% |
| 2018 Q4 | 27.91 Million EUR | 17.75% |
| 2018 Q3 | 23.71 Million EUR | -39.19% |
| 2018 Q2 | 38.99 Million EUR | 89.33% |
| 2017 Q4 | 16.03 Million EUR | 2.42% |
| 2017 Q3 | 15.65 Million EUR | -14.65% |
| 2017 Q2 | 18.33 Million EUR | 0.8% |
| 2017 Q1 | 18.19 Million EUR | 32.2% |
| 2017 FY | 16.03 Million EUR | 16.48% |
| 2016 Q2 | 226.09 Thousand EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 FY | 13.76 Million EUR | 7321.68% |
| 2016 Q4 | 13.76 Million EUR | 1.22% |
| 2016 Q3 | 13.59 Million EUR | 5913.93% |
| 2015 Q4 | 185.43 Thousand EUR | 0.0% |
| 2015 FY | 185.43 Thousand EUR | 106.53% |
| 2015 Q2 | 72.41 Thousand EUR | 0.0% |
| 2014 Q4 | 89.78 Thousand EUR | 0.0% |
| 2014 FY | 89.78 Thousand EUR | -60.37% |
| 2014 Q2 | 243 Thousand EUR | 0.0% |
| 2013 Q2 | 191 Thousand EUR | 0.0% |
| 2013 Q4 | 226.54 Thousand EUR | 0.0% |
| 2013 FY | 226.54 Thousand EUR | -15.52% |
| 2012 Q2 | 258 Thousand EUR | 0.0% |
| 2012 Q4 | 268.14 Thousand EUR | 0.0% |
| 2012 FY | 268.14 Thousand EUR | -4.48% |
| 2011 FY | 280.72 Thousand EUR | -45.84% |
| 2011 Q4 | 280.72 Thousand EUR | 0.0% |
| 2011 Q2 | 455 Thousand EUR | 0.0% |
| 2010 Q4 | 518.32 Thousand EUR | 0.0% |
| 2010 FY | 518.32 Thousand EUR | 117.75% |
| 2010 Q2 | 3.78 Million EUR | 0.0% |
| 2009 Q4 | 3.54 Million EUR | 0.0% |
| 2009 FY | -2.92 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | 79.993% |
| Guerbet SA | 646.97 Million EUR | 80.533% |
| Nexus AG | 153.13 Million EUR | 17.754% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | 77.761% |
| Revenio Group Oyj | 37.6 Million EUR | -234.963% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 93.182% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 98.2% |
| LNA Santé SA | 1.19 Billion EUR | 89.492% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.559% |
| Equasens Société anonyme | 166.41 Million EUR | 24.32% |
| Stratec SE | 246.2 Million EUR | 48.845% |